Archives of Plastic Surgery

Korean Society of Plastic and Reconstructive Surgeons (대한성형외과학회)
권호 표지
DOI QR코드

DOI QR Code

Breast implant-associated anaplastic large cell lymphoma in an Asian patient: The first case report from Thailand

  • Received : 2020.01.24
  • Accepted : 2020.05.07
  • Published : 2020.09.15
Download PDF
⟨ Previous Next ⟩

Abstract

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) has received increasing interest among plastic surgeons as a long-term complication of breast augmentation. Although the prognosis is usually good, mortality is a possible outcome. Most of the cases reported in the past two decades have been from the United States, Europe, and Australia, whereas cases of BIA-ALCL in Asia remain rare. Herein, we describe the first known case of BIA-ALCL in Thailand, in which a 32-year-old woman developed BIA-ALCL 3 years after breast augmentation using textured implants. The patient underwent bilateral removal of the implants and ipsilateral total capsulectomy. This case report-the first of its kind from Thailand-should increase awareness of BIA-ALCL among plastic surgeons in Asia. The true incidence of BIA-ALCL in Asia may be underreported.

Keywords

References

  1. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016;127:2375-90. https://doi.org/10.1182/blood-2016-01-643569
  2. de Jong D, Vasmel WL, de Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA 2008; 300:2030-5. https://doi.org/10.1001/jama.2008.585
  3. US Food and Drug Administration. Medical device reports of breast implant-associated anaplastic large cell lymphoma [Internet]. Silver Spring, MD: US Food and Drug Administration; c2019 [cited 2020 May 22]. Available from: https://www.fda.gov/medical-devices/breast-implants/medical-device-reports-breast-implant-associated-anaplastic-large-cell-lymphoma.
  4. Magnusson M, Beath K, Cooter R, et al. The epidemiology of breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand confirms the highest risk for grade 4 surface breast implants. Plast Reconstr Surg 2019; 143:1285-92. https://doi.org/10.1097/PRS.0000000000005500
  5. Clemens MW, Nava MB, Rocco N, et al. Understanding rare adverse sequelae of breast implants: anaplastic large-cell lymphoma, late seromas, and double capsules. Gland Surg 2017;6:169-84. https://doi.org/10.21037/gs.2016.11.03
  6. Clemens MW, Jacobsen ED, Horwitz SM. 2019 NCCN consensus guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Aesthet Surg J 2019;39(Suppl_1):S3-13. https://doi.org/10.1093/asj/sjy331
  7. Collett DJ, Rakhorst H, Lennox P, et al. Current risk estimate of breast implant-associated anaplastic large cell lymphoma in textured breast implants. Plast Reconstr Surg 2019;143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):30S-40S. https://doi.org/10.1097/PRS.0000000000005567
  8. Bizjak M, Selmi C, Praprotnik S, et al. Silicone implants and lymphoma: the role of inflammation. J Autoimmun 2015; 65:64-73. https://doi.org/10.1016/j.jaut.2015.08.009
  9. Hu H, Jacombs A, Vickery K, et al. Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma. Plast Reconstr Surg 2015;135:319-29. https://doi.org/10.1097/PRS.0000000000000886
  10. Stevens WG, Calobrace MB, Alizadeh K, et al. Ten-year core study data for Sientra's Food and Drug Administration-approved round and shaped breast implants with cohesive silicone gel. Plast Reconstr Surg 2018;141(4S Sientra Shaped and Round Cohesive Gel Implants):7S-19S. https://doi.org/10.1097/PRS.0000000000004350
  11. Jones P, Mempin M, Hu H, et al. The functional influence of breast implant outer shell morphology on bacterial attachment and growth. Plast Reconstr Surg 2018;142:837-49. https://doi.org/10.1097/PRS.0000000000004801
  12. Loch-Wilkinson A, Beath KJ, Knight RJW, et al. Breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plast Reconstr Surg 2017; 140:645-54. https://doi.org/10.1097/PRS.0000000000003654
  13. Hu H, Johani K, Almatroudi A, et al. Bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma. Plast Reconstr Surg 2016;137:1659-69. https://doi.org/10.1097/PRS.0000000000002010
  14. Walker JN, Hanson BM, Pinkner CL, et al. Insights into the microbiome of breast implants and periprosthetic tissue in breast implant-associated anaplastic large cell lymphoma. Sci Rep 2019;9:10393. https://doi.org/10.1038/s41598-019-46535-8
  15. Leberfinger AN, Behar BJ, Williams NC, et al. Breast implant-associated anaplastic large cell lymphoma: a systematic review. JAMA Surg 2017;152:1161-8. https://doi.org/10.1001/jamasurg.2017.4026

Cited by

  1. Current status of breast implant-associated anaplastic large cell lymphoma in South Korea vol.64, pp.1, 2020, https://doi.org/10.5124/jkma.2021.64.1.5
  2. Analysis of the Molecular Signature of Breast Implant-Associated Anaplastic Large Cell Lymphoma in an Asian Patient vol.41, pp.5, 2021, https://doi.org/10.1093/asj/sjaa398
  3. Breast implant-associated anaplastic large cell lymphoma: a case report with a history of spontaneously resolved late seroma vol.27, pp.4, 2021, https://doi.org/10.14730/aaps.2021.00136